Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
JP Stock MarketDetailed Quotes
4594 BrightPath Biotherapeutics
- 45
- -1-2.17%
20min DelayMarket Closed Dec 30 15:30 JST
3.90BMarket Cap-2.47P/E (Static)
47High44Low944.10KVolume45Open46Pre Close43.04MTurnover9952wk High1.17%Turnover Ratio86.69MShares4152wk Low-16.51EPS TTM3.63BFloat Cap2229Historical HighLossP/E (Static)80.74MShs Float41Historical Low-18.21EPS LYR6.52%Amplitude--Dividend TTM3.11P/B100Lot Size--Div YieldTTM
About BrightPath Biotherapeutics Company
BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.
Company Profile
Symbol4594
Company NameBrightPath Biotherapeutics
Founded2003-05-08
MarketTSE Growth
Fiscal Year Ends03-31
Address2-2-4 Kojimachi Kojimachi Central Building 7th Floor
Zip Code102-0083
Phone03-5840-7697
Websitewww.brightpathbio.com
Company Executives
- Name
- Position
- Salary
- Yoichi Takeshita
- Director and Chief Financial Officer
- --
- Kenichi Nagai
- Representative Director and President
- --
- Tokuhiro Nakamura
- Director and Director of Drug Discovery Research
- --
- Ryo Yamada
- Director
- --
- Hirotaka Takeuchi
- Independent Director
- --